143 related articles for article (PubMed ID: 34705829)
41. Proteome-wide screening for designing a multi-epitope vaccine against emerging pathogen
Nain Z; Abdulla F; Rahman MM; Karim MM; Khan MSA; Sayed SB; Mahmud S; Rahman SMR; Sheam MM; Haque Z; Adhikari UK
J Biomol Struct Dyn; 2020 Oct; 38(16):4850-4867. PubMed ID: 31709929
[No Abstract] [Full Text] [Related]
42. Immunoinformatics-Aided Design and Evaluation of a Potential Multi-Epitope Vaccine against
Dar HA; Zaheer T; Shehroz M; Ullah N; Naz K; Muhammad SA; Zhang T; Ali A
Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31409021
[No Abstract] [Full Text] [Related]
43. Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach.
Kalita P; Lyngdoh DL; Padhi AK; Shukla H; Tripathi T
Int J Biol Macromol; 2019 Oct; 138():224-233. PubMed ID: 31279880
[TBL] [Abstract][Full Text] [Related]
44. In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases.
Shey RA; Ghogomu SM; Esoh KK; Nebangwa ND; Shintouo CM; Nongley NF; Asa BF; Ngale FN; Vanhamme L; Souopgui J
Sci Rep; 2019 Mar; 9(1):4409. PubMed ID: 30867498
[TBL] [Abstract][Full Text] [Related]
45. Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches.
Ikram A; Zaheer T; Awan FM; Obaid A; Naz A; Hanif R; Paracha RZ; Ali A; Naveed AK; Janjua HA
Sci Rep; 2018 Oct; 8(1):16107. PubMed ID: 30382118
[TBL] [Abstract][Full Text] [Related]
46. The Immune Epitope Database (IEDB): 2018 update.
Vita R; Mahajan S; Overton JA; Dhanda SK; Martini S; Cantrell JR; Wheeler DK; Sette A; Peters B
Nucleic Acids Res; 2019 Jan; 47(D1):D339-D343. PubMed ID: 30357391
[TBL] [Abstract][Full Text] [Related]
47. Comparative Studies of the Dynamics Effects of BAY60-2770 and BAY58-2667 Binding with Human and Bacterial H-NOX Domains.
Rehan Khalid R; Tahir Ul Qamar M; Maryam A; Ashique A; Anwar F; H Geesi M; Siddiqi AR
Molecules; 2018 Aug; 23(9):. PubMed ID: 30149624
[TBL] [Abstract][Full Text] [Related]
48. Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic approaches.
Chatterjee N; Ojha R; Khatoon N; Prajapati VK
Int J Biol Macromol; 2018 Oct; 118(Pt A):180-188. PubMed ID: 29920369
[TBL] [Abstract][Full Text] [Related]
49. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.
Kumar Pandey R; Ojha R; Mishra A; Kumar Prajapati V
J Cell Biochem; 2018 Sep; 119(9):7631-7642. PubMed ID: 29900580
[TBL] [Abstract][Full Text] [Related]
50. HPEPDOCK: a web server for blind peptide-protein docking based on a hierarchical algorithm.
Zhou P; Jin B; Li H; Huang SY
Nucleic Acids Res; 2018 Jul; 46(W1):W443-W450. PubMed ID: 29746661
[TBL] [Abstract][Full Text] [Related]
51. Immunoinformatics approaches to design a novel multi-epitope subunit vaccine against HIV infection.
Pandey RK; Ojha R; Aathmanathan VS; Krishnan M; Prajapati VK
Vaccine; 2018 Apr; 36(17):2262-2272. PubMed ID: 29571972
[TBL] [Abstract][Full Text] [Related]
52. Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Adhikari UK; Rahman MM
Infect Genet Evol; 2017 Dec; 56():75-91. PubMed ID: 29107145
[TBL] [Abstract][Full Text] [Related]
53. Multi-epitope vaccines: a promising strategy against tumors and viral infections.
Zhang L
Cell Mol Immunol; 2018 Feb; 15(2):182-184. PubMed ID: 28890542
[No Abstract] [Full Text] [Related]
54. PDBsum: Structural summaries of PDB entries.
Laskowski RA; Jabłońska J; Pravda L; Vařeková RS; Thornton JM
Protein Sci; 2018 Jan; 27(1):129-134. PubMed ID: 28875543
[TBL] [Abstract][Full Text] [Related]
55. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection.
Ali M; Pandey RK; Khatoon N; Narula A; Mishra A; Prajapati VK
Sci Rep; 2017 Aug; 7(1):9232. PubMed ID: 28835708
[TBL] [Abstract][Full Text] [Related]
56. Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach.
Khatoon N; Pandey RK; Prajapati VK
Sci Rep; 2017 Aug; 7(1):8285. PubMed ID: 28811600
[TBL] [Abstract][Full Text] [Related]
57. An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.
Bonam SR; Partidos CD; Halmuthur SKM; Muller S
Trends Pharmacol Sci; 2017 Sep; 38(9):771-793. PubMed ID: 28668223
[TBL] [Abstract][Full Text] [Related]
58. Effect of linker length and residues on the structure and stability of a fusion protein with malaria vaccine application.
Shamriz S; Ofoghi H; Moazami N
Comput Biol Med; 2016 Sep; 76():24-9. PubMed ID: 27393958
[TBL] [Abstract][Full Text] [Related]
59. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches.
Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y
Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181
[TBL] [Abstract][Full Text] [Related]
60. The role of structural proteomics in vaccine development: recent advances and future prospects.
Donnarumma D; Faleri A; Costantino P; Rappuoli R; Norais N
Expert Rev Proteomics; 2016; 13(1):55-68. PubMed ID: 26714563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
